Correlates of multi-drug resistant tuberculosis: a case control study from a hilly district of North India

Salig Ram Mazta; Harshvardhan Singh; Prem Lal

doi:10.18203/2394-6040.ijcmph20172869

Authors

Salig Ram Mazta Department of Community Medicine, Indira Gandhi Medical College, Shimla, H.P.
Harshvardhan Singh Department of Community Medicine, Indira Gandhi Medical College, Shimla, H.P. http://orcid.org/0000-0002-7389-0417
Prem Lal Department of Community Medicine, Indira Gandhi Medical College, Shimla, H.P.

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20172869

Keywords:

Tuberculosis, MDR-TB, Case control study

Abstract

Background: Drug resistance has emerged as a major threat to global TB control efforts in recent years. India, with the highest burden of Tuberculosis worldwide, faces a looming epidemic of drug resistant TB due to initial irrational, irregular and incomplete treatment outside the purview of the robust national programme. Himachal Pradesh, a north Indian hilly state with a population of about 7 million has a considerable burden of Tuberculosis with geographical challenges. The present study envisaged to identify the potential risk factors to the emergence of drug resistance TB in the settings of district Shimla.

Methods: A pilot case control study, all patients (n=11) enrolled for MDR-TB in Tuberculosis Unit Shimla during the period (2013-14) were included. 3 of who died were excluded. Thrice the number of controls (n=24) were selected after matching for age, sex and approximate geographical location.

Results: The univariate analysis showed that, compared with controls, risk factors significantly associated with primary MDR-TB were Socioeconomic status lower than class 3 (OR=13.8; p=0.02), poor ventilation (OR=5; p=0.05), absent BCG scar (OR=23; p=0.002), history of default (p=0.002) and initial treatment from a private practitioner (OR=6.60; p=0.04). The Multivariate analysis showed that the risk factors independently associated with primary MDR-TB were absent BCG scar (OR=28.15; 95% CI=1.51524.38) and initial irrational and incomplete treatment from a private practitioner (OR=16.77; 95% CI =1.12-319.26).

Conclusions: In our stud, poor ventilation, lower socioeconomic condition and initial default have been found to be significantly associated with the disease whereas absent BCG scar and initial irrational treatment from private practitioners have emerged as independent risk factors for the emergence of drug resistant Tuberculosis further reiterating the need for strengthening Immunization and early diagnosis and treatment aspect of the disease involving private practitioners. Larger and extensive studies on these aspects are further warranted.

Metrics

Metrics Loading ...

References

WHO. Global tuberculosis report 2014. World Health Organization. Available at: http://www.who.int/tb/publications/global_report/en/ Accessed on 3 March 2017.

Central TB Division. TB India 2014 Annual status report. New Delhi:Central TB division, Directorate General of Health Services, Ministry of Health and Family Welfare, Govt. of India;2016.

Atre SR, D’Souza DTB, Vira TS, Chatterjee A, Mistry NF. Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J Public Health. 2011;55(1):14–21.

Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, et al. Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One. 2010;5(3):e9527.

Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J. 2009;33(5):1085–94.

Gaude GS, Hattiholli J, Kumar P. Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India. Niger Med J. 2014;55(4):327–32.

Wang K, Chen S, Wang X, Zhong J, Wang X, Huai P, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients:a case-control study from China. Microb Drug Resist. 2014;20(4):294–300.

Li X-X, Lu W, Zu R-Q, Zhu L-M, Yang H-T, Chen C, et al. Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu province, China: a matched-pairs case-control study. Am J Trop Med Hyg. 2015;92(2):280–5.

Mittal C, Gupta S. Noncompliance to DOTS: How it can be decreased. Indian J Community Med. 2011;36(1):27–30.

Slama K, Chiang C-Y, Enarson D A, Hassmiller K, Fanning A, Gupta P, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007;11:1049–61.

Tachfouti N, Nejjari C, Benjelloun MC, Berraho M, Elfakir S, El Rhazi K, et al. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis. 2011;15(6):838–43.

Lönnroth K, Williams BG, Stadlin S, Jaramillo, Dye C. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health. 2008;8:289.

Mellencamp M. Symposium: Effects of Ethanol Consumption on Susceptibility to Pulmonary and Gastrointestinal Infections. Alcohol Clin Exp Res. 1996;20:192-5.

Szabo G. Alcohol's Contribution to Compromised Immunity. Alcohol, Health Res World. 1997;21(1):30-41.

Ndwandwe ZSI, Mahomed S, Lutge E, Knight SE. Factors affecting non-adherence to tuberculosis treatment in uMgungundlovu Health District. South Afr J Infect Dis. 2014;29(2):56-9.

Gebrezgabiher G, Romha G, Ejeta E, Asebe G, Zemene E, Ameni G. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study. PLoS ONE. 2016;11(2):e0150560.

Reddy DS, Rao R, Kumar BPR. Factors Influencing Treatment Outcome of New Sputum Smear Positive Tuberculosis Patients In Tuberculosis Unit Khammam. Int J Med Health Sci. 2013;2(2):195-204.